Google DeepMind's AlphaGenome, AI in Lung Cancer Detection, and $120M AI Drug Deal

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in AI within the healthcare and life sciences sectors. This week, we highlight a range of collaborations and innovations that are shaping the future of medical technology. Radiology Partners and Stanford Radiology's AIDE Lab are working together to improve the safety of AI tools in medical imaging, while Medaptus and athenahealth are teaming up to automate charge capture for healthcare providers. In the realm of drug development, Qilu Pharmaceutical and Insilico Medicine have embarked on a $120 million partnership to create AI-driven small molecules for cardiometabolic diseases.

In other news, NHS England is trialing AI technology to enhance lung cancer detection, and Oracle has launched a new AI platform aimed at boosting research in life sciences. Meanwhile, AEYE Health is expanding its integration with Epic to improve diabetic eye screening, and Google DeepMind has introduced AlphaGenome, an AI model for DNA analysis. These stories, among others, underscore the transformative impact of AI in healthcare, promising improved patient outcomes and more efficient medical processes.

Radiology Partners and Stanford AIDE Lab Partner for AI Safety

Radiology Partners and Stanford Radiology's AIDE Lab have announced a strategic partnership to enhance the safety and reliability of AI tools in medical imaging. Read more

Medaptus and athenahealth Collaborate on AI Charge Capture

Medaptus has partnered with athenahealth to automate charge capture and enhance revenue integrity for healthcare providers through their Charge Pro software. Read more

Qilu Pharmaceutical and Insilico Medicine in $120M AI Drug Development Deal

Qilu Pharmaceutical has partnered with Insilico Medicine to invest up to $120 million in developing AI-driven small molecules for cardiometabolic diseases. The collaboration focuses on optimizing drug candidates for obesity and Type 2 diabetes. Read more

Partsol Unveils AI Stem Cells for Cognitive Intelligence

Partsol has announced their new AI Stem Cells, aimed at enhancing cognitive intelligence with a focus on truth-based systems. This development promises structured growth and increased reliability for critical industries. Read more

NHS England Trials AI for Lung Cancer Detection

NHS England is trialing AI and robotic technology to improve lung cancer detection and diagnosis. The initiative aims to screen all smokers and ex-smokers by 2030 and diagnose 50,000 cases by 2035. Read more

Healthcare Triangle Partners with Better.care for AI Health Services

Healthcare Triangle Inc. has partnered with Better.care to enhance health data platform services across Europe, Southeast Asia, the Middle East, and Africa. The collaboration aims to improve digital health innovation and patient care. Read more

Fractional AI Launches Healthcare Division

Fractional AI has announced the creation of Fractional AI Health, a new division aimed at enhancing healthcare with AI solutions. The division will focus on improving operational efficiency, revenue growth, and clinical outcomes in the healthcare sector. Read more

Oracle Unveils AI Platform for Life Sciences

Oracle has launched the Life Sciences AI Data Platform, designed to enhance research and commercial success in the pharmaceutical and medical sectors by integrating diverse datasets for deeper insights. Read more

Nucs AI Forms Medical Advisory Board for Cancer Care

Nucs AI has established a Medical Advisory Board with experts in radiology, nuclear medicine, oncology, and clinical research to guide the integration of AI in cancer care, ensuring alignment with clinical practices. Read more

AEYE Health Expands Epic Integration for AI Eye Screening

AEYE Health has announced an expanded integration with Epic to enhance AI-driven diabetic eye screening across the US, allowing quick exam orders and results. Read more

Institute of Cancer Research Receives Funding for AI Project

The Institute of Cancer Research in London has been granted nearly £400,000 by the Medical Research Council for the FIREDANSE project, which aims to enhance AI safety and transparency in healthcare. Read more

Google DeepMind Unveils AlphaGenome for DNA Analysis

Researchers at Google DeepMind have launched AlphaGenome, an AI model designed to analyze DNA code and aid in disease research by predicting mutation impacts on gene regulation. Read more

Sword Health Acquires Kaia Health for $285 Million

Sword Health has acquired Kaia Health for $285 million, enhancing its AI Care platform and expanding its reach to 100 million people in the U.S. and Germany. Read more

Enamine and Chemspace Join IHI Project for AI Drug Discovery

Enamine and Chemspace have announced their participation in the IHI Project LIGAND-AI, which aims to enhance AI-driven drug discovery. The project involves 18 partners and focuses on creating datasets for AI models to predict drug candidates. Read more

Thoma Bravo Considers Selling Imprivata

Private equity firm Thoma Bravo is exploring the sale of Imprivata, a digital identity software provider for healthcare, with potential valuations up to $7 billion. The process is in early stages with involvement from investment banks JPMorgan and Evercore. Read more

Alan Seeks €100 Million Funding at €5 Billion Valuation

French health startup Alan is in talks to secure over €100 million in funding, aiming for a valuation of €5 billion. The company plans to expand its customer base by integrating health insurance with healthcare services. Read more

Cognizant Partners with Uniphore for AI Solutions

Cognizant has announced a strategic partnership with Uniphore to develop industry-specific AI solutions. The collaboration will focus on integrating AI capabilities into business workflows, starting with Life Sciences and Banking sectors. Read more

Presbyterian Healthcare Expands AI Platform to 200 Clinicians

Presbyterian Healthcare Services has expanded its GW RhythmX AI Precision Care Platform to 200 primary care clinicians. This move aims to enhance care delivery by reducing manual data review and improving patient condition identification. Read more

Deep EigenMatics Leads AI Drug Discovery Patents in 2025

Deep EigenMatics, Inc. has achieved the top global ranking for new U.S. patent families in AI Drug Discovery methods for 2025, surpassing the combined output of Big Pharma. The company focuses on the Oral GLP-1 category as its lead therapeutic target. Read more

Virtual Science AI Unveils Medical Congress AI

Virtual Science AI has launched Medical Congress AI, a conversational AI tool for analyzing insights from medical congress discussions in real-time. Read more

Beckman Coulter Partners with Automata for Lab Automation

Beckman Coulter Life Sciences has partnered with Automata to enhance laboratory automation through integrated technologies. This collaboration aims to improve research workflow reliability and data integrity. Read more

Optellum Partners with NHS for AI Lung Cancer Diagnostics

Optellum has been chosen by the NHS to deploy its AI-driven lung cancer diagnostic tool, the Virtual Nodule Clinic, to enhance early detection and reduce invasive procedures. The initiative will begin at Guy's and St Thomas' NHS Foundation Trust in London. Read more

Biorce Raises $52.5 Million for AI Clinical Trial Platform

Spanish healthtech company Biorce has secured $52.5 million in Series A funding to expand its AI-driven clinical trial platform, Aika, and enter the US market. Read more

Anthropic Collaborates with Institutes to Boost AI in Biology

Anthropic has formed partnerships with the Allen Institute and the Howard Hughes Medical Institute to advance AI applications in biological research. The collaboration focuses on improving data analysis and experimental processes in life sciences. Read more

Emerald Raises $2 Million for AI in Healthcare

Emerald has raised $2 million in pre-seed funding to integrate AI into blood testing and medical care, aiming to enhance healthcare delivery. Read more

BlueFive Capital Closes $3 Billion Fund for AI and Biotech

BlueFive Capital has finalized its $3 billion Onyx Fund I, targeting investments in AI, biotechnology, and advanced computing in the US and Europe, with backing from Gulf region sovereign capital. Read more

AI Framework PURE Developed for Drug Discovery

Researchers from The Ohio State University and the Indian Institute of Technology Madras have developed an AI framework called PURE to aid in generating drug-like molecules, aiming to streamline the drug development process. Read more

University of Leicester Develops AI Tool for Cancer Patients' Heart Attack Risks

Researchers at University of Leicester have developed an AI tool called ONCO-ACS to predict the risk of secondary heart attacks in cancer patients by analyzing clinical data and cancer-related factors. Read more

XtalPi Unveils AI Platform for Drug Discovery

At the 2026 International Symposium, XtalPi launched its AI-driven XGlue™ platform to enhance molecular glue drug discovery, focusing on undruggable protein targets. Read more

Categories

Companies

Resources

Google DeepMind's AlphaGenome, AI in Lung Cancer Detection, and $120M AI Drug Deal - Life AI Weekly #53

We hope you enjoyed this article.

More from: Life Sciences

Subscribe to Life AI Weekly